Article ; Online: Intravenous Magnesium in Asthma Pharmacotherapy: Variability in Use in the PECARN Registry.
2020 Volume 220, Page(s) 165–174.e2
Abstract: ... in children with asthma whose emergency department (ED) management is recorded in the Pediatric Emergency Care ... between sites, which suggests the current clinical role for IVMg in preventing hospitalization is limited ... for acute asthma and its effect on blood pressure. We also used multivariable analysis to examine factors ...
| Abstract | Objective: To examine the use, efficacy, and safety of intravenous magnesium sulfate (IVMg) in children with asthma whose emergency department (ED) management is recorded in the Pediatric Emergency Care Applied Research Network (PECARN) Registry. Study design: This multicenter retrospective cohort study analyzed clinical data from 7 EDs from 2012 to 2017. We described use of IVMg in children aged 2-17 years treated for acute asthma and its effect on blood pressure. We also used multivariable analysis to examine factors associated with use of IVMg and its association with return visits within 72 hours. Results: Across 61 854 asthma visits for children, clinicians administered IVMg in 6497 (10.5%). Median time from triage to IVMg administration was 154 minutes (IQR 84, 244). During 22 495 ED visits resulting in hospitalization after ED treatment, IVMg was administered in 5774 (25.7%) (range by site 15.9%, 50.6%). Patients were discharged home from the ED after 11.1% of IVMg administrations, and hypotension occurred after 6.8%. Variation in IVMg use was not explained by patient characteristics. Revisits did not differ between patients discharged after IVMg and those not receiving IVMg. Conclusions: In PECARN Registry EDs, administration of IVMg occurs late in ED treatment, for a minority of the children likely to benefit, with variation between sites, which suggests the current clinical role for IVMg in preventing hospitalization is limited. Discharge after IVMg administration is likely safe. Further research should prospectively assess the efficacy and safety of early IVMg administration. |
|---|---|
| MeSH term(s) | Acute Disease ; Administration, Intravenous ; Adolescent ; Asthma/drug therapy ; Child ; Child, Preschool ; Cohort Studies ; Drug Utilization/statistics & numerical data ; Emergency Treatment ; Female ; Humans ; Magnesium/administration & dosage ; Magnesium/adverse effects ; Male ; Registries ; Retrospective Studies ; Treatment Outcome ; United States |
| Chemical Substances | Magnesium (I38ZP9992A) |
| Language | English |
| Publishing date | 2020-03-05 |
| Publishing country | United States |
| Document type | Journal Article ; Multicenter Study ; Research Support, U.S. Gov't, P.H.S. |
| ZDB-ID | 3102-1 |
| ISSN | 1097-6833 ; 0022-3476 |
| ISSN (online) | 1097-6833 |
| ISSN | 0022-3476 |
| DOI | 10.1016/j.jpeds.2020.01.062 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Um IV Zs.116: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.